Predictive Oncology
POAI
POAI
30 hedge funds and large institutions have $1.86M invested in Predictive Oncology in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
53% less capital invested
Capital invested by funds: $3.96M → $1.86M (-$2.11M)
Holders
30
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$160K | |
| 2 | +$65K | |
| 3 | +$44K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$15.9K |
| 5 |
Millennium Management
New York
|
+$6K |
Top Sellers
| 1 | -$54K | |
| 2 | -$53K | |
| 3 | -$25K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$13K |
| 5 |
NC
NewSquare Capital
Newtown Square,
Pennsylvania
|
-$5K |